SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

BofA Securities Raises Keros Therapeutics Price Target to $18 From $17

Valid market news retained in the public archive without immediate LiveCast distribution.

KROS

Related stories